Abstract: The present invention relates to a group of compounds derived from resveratrol having as substituents at least one silyl group which, in turn, can be substituted by different groups. The invention also relates to the therapeutic use of these compounds in inflammatory, neurological, and neurodegenerative diseases.

Abstract: A therapeutic use of acylated piceid derivative compounds in ocular pathologies, in particular retinitis pigmentosa and in age-related macular degeneration, inter alia. A method of treating and/or preventing ocular pathologies, wherein the method includes administering to a patient in need of treatment a therapeutically effective amount of a compound of general formula (I) or any of its isomers, their pharmaceutically acceptable salts, esters, tautomers, polymorphs, or hydrates.

Abstract: The present invention relates to the therapeutic use of acylated piceid derivative compounds in ocular pathologies, in particular retinitis pigmentosa and in age-related macular degeneration.

Abstract: Systems and methods are provided for modeling fluid flow in a turbomachine. A specification of a system including first and second blade rows is received. A wake profile from the first blade row is imposed on the second blade row to approximate an influence of the first blade row on the second blade row. Governing flow equations for the fluid flow in the second blade row are transformed in time. Flow variables of the transformed governing flow equations are represented as a Fourier series, and the Fourier series representation is substituted into the transformed governing flow equations to obtain a modified form of the transformed governing flow equations. A pseudo-time term is introduced into the modified form of the transformed governing flow equations. The modified form of the transformed governing flow equations is solved using the steady-state solution method to model the fluid flow in the second blade row.

Abstract: Systems and methods are provided for modeling fluid flow in a turbomachine. A specification of a system including at least a stator and a rotor of a turbomachine is received. The stator is coupled to the rotor via a profile-transformation (PT) interface. A flow profile for fluid flow across the PT interface is expanded or compressed based on a pitch ratio between the stator and the rotor. Flow variables of governing flow equations for the fluid flow in the system are represented as a Fourier series with spatially-varying Fourier coefficients. The Fourier series representation is substituted into the governing flow equations to obtain a modified form of the governing flow equations. The modified form of the governing flow equations is solved using a steady-state solution method to model the fluid flow in the system. The modeling utilizes an implicit solution discretization across the PT interface.

Abstract: Systems and methods are provided for modeling fluid flow in a turbomachine. A specification of a system is received. The system includes multiple passages, where the multiple passages include at least an inlet guide vane, a rotor, and a stator. A computational grid is generated with a processing system based on the received specification. Governing flow equations for the system are transformed based on inclination parameters, where each passage of the system has an associated inclination parameter. A rotational velocity of rotating passages included in the system is specified, and a time-step for stationary passages included in the system is specified. Time-steps for the rotating passages included in the system are computed, where the time-steps are computed based on pitch-ratios for adjacent passages of the system. A solution for the system is advanced in time by solving the transformed governing flow equations across the computational grid using computer-based numerical calculations.

Abstract: The present invention relates to a group of compounds derived from resveratrol having as substituents at least one silyl group which, in turn, can be substituted by different groups. The invention also relates to the therapeutic use of these compounds in inflammatory, neurological, and neurodegenerative diseases.

Abstract: The present invention relates to the therapeutic use of acylated piceid derivative compounds in ocular pathologies, in particular retinitis pigmentosa and in age-related macular degeneration.

Abstract: A mobile phone mounting kit. The mobile phone mounting kit may comprise: a case, magnetic mounting platform, vehicle mounting arm, and air vent clips. The magnetic mounting platform may attach to a first end of the vehicle mounting arm, and the second end of the vehicle mounting arm may comprises a suction cup for attaching onto a surface. The magnetic mounting platform may comprises a magnet. The case may be configured to house a mobile phone and comprises one or more metal plates for attaching and securing to the magnet of the magnetic mounting platform. The case may comprises: a charging port, wires, charging contacts; and metal plates. The charging contacts may electrically communicate with a battery of the mobile phone. The charging port may mate and engage a connector of a power cable for charging the mobile phone by transferring an electrical current from the charging port to the charging contacts via the wires.

Abstract: Compounds of general formula (I) for the treatment of inflammatory processes involved in numerous diseases such as intestinal inflammatory diseases. The invention moreover refers to compounds included within such general formula and to the procedure of the obtainment thereof.

Abstract: The present invention refers to the use of phenolic compounds and their derivatives represented by formula I wherein R1 and R2 are selected from among: OH, OCOalkyl, or OCOalkenyl, and R3 is either H, OH, OCOalkyl or OCOalkenyl, wherein the alkyl or alkenyl chains present from 2 to 22 carbon atoms and wherein at least one OCOalkyl or OCOalkenyl group is present in the structure, for the prevention and treatment of cardiovascular, hepatic or renal diseases, as well as to their cosmetic applications, to compositions that include these compounds and to some novel phenolic compounds and derivatives.

Abstract: The invention relates to the use of phenolic compounds and derivatives thereof for protection against neurodegenerative diseases, to compositions comprising these compounds, and to some novel phenolic compounds.

Abstract: The present invention refers to the use of phenolic compounds and their derivatives represented by formula I wherein R1 and R2 are selected from among: OH, OCOalkyl, or OCOalkenyl, and R3 is either H, OH, OCOalkyl or OCOalkenyl, wherein the alkyl or alkenyl chains present from 2 to 22 carbon atoms and wherein at least one OCOalkyl or OCOalkenyl group is present in the structure, for the prevention and treatment of cardiovascular, hepatic or renal diseases, as well as to their cosmetic applications, to compositions that include these compounds and to some novel phenolic compounds and derivatives.